Vanda Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Vanda Pharmaceuticals Inc
CIK #0001347178
EDGAR Form CIK 2011 - 2026
10-K [0001347178]
10-Q [0001347178]
3 [0001347178]
4 [0001347178]
5 [0001347178]
8-K [0001347178]
SC 13G [0001347178]
Form 13D/13G Filer Form 13D/13G Subject Filed
State Street Corp Vanda Pharmaceuticals Inc [2026-05-12]
Millennium Management LLC Vanda Pharmaceuticals Inc [2025-07-01]
BlackRock Portfolio Management LLC Vanda Pharmaceuticals Inc [2025-04-15]
Dimensional Fund Advisors LP Vanda Pharmaceuticals Inc [2023-02-10]
State Street Corp Vanda Pharmaceuticals Inc [2021-02-11]
BlackRock Inc Vanda Pharmaceuticals Inc [2021-01-25]
Renaissance Technologies LLC Vanda Pharmaceuticals Inc [2020-02-12]
Armistice Capital LLC Vanda Pharmaceuticals Inc [2019-06-24]
Consonance Capital Management LP Vanda Pharmaceuticals Inc [2019-02-14]
Macquarie Group Ltd Vanda Pharmaceuticals Inc [2018-02-14]
View All
Form 3/4/5 Subject 2011 - 2026
Honore Tage
Vanda Pharmaceuticals Inc
Dugan Richard W
McGuire Daniel Patrick
Chrousos Phaedra
Duncan Charles Cliff
Ward Anne Sempowski
Mitchell Stephen Ray
Howell Scott Laverne
Polymeropoulos Christos Vasilios Mihael
Williams Timothy
Birznieks Gunther
Polymeropoulos Mihael Hristos
Moran Kevin Patrick
Wijkstrom Joakim
Watkins Thomas
Jones Aranthan II
Reverberi Gian Piero
Kelly James Patrick
Cola Michael F
Milano Vincent
Gulino Richard L
Bate Kenneth
Baroldi Paolo
Deerfield Special Situations Fund LP
Deerfield Management Company LP
Deerfield Capital LP
Deerfield International Master Fund LP
Deerfield Partners LP
Flynn James E
Pien Howard H
Gibbs Thomas Edward
Deerfield Special Situations International Master Fund LP
Galson Steven K
Repella Robert
Feeney John Joseph
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Vanda Pharmaceuticals Inc VNDA
Common Stock
2026-03-02 Sell 30,800 $8.27 254,716
Vanda Pharmaceuticals Inc VNDA
Common Stock
2026-03-02 Sell 42,442 $8.27 350,995
Vanda Pharmaceuticals Inc VNDA
Common Stock
2026-03-02 Sell 42,434 $8.27 350,929
Vanda Pharmaceuticals Inc VNDA
Common Stock
2026-03-02 Sell 156,235 $8.17 1,276,440
Vanda Pharmaceuticals Inc VNDA
Common Stock
2026-03-02 Sell 42,431 $8.27 350,904
Vanda Pharmaceuticals Inc VNDA
Common Stock
2026-02-23 Sell 30,000 $8.03 240,900
Vanda Pharmaceuticals Inc VNDA
Common Stock
2026-02-18 Grant 125,000 $0.00
Vanda Pharmaceuticals Inc VNDA
Common Stock
2026-02-18 Grant 525,000 $0.00
Vanda Pharmaceuticals Inc VNDA
Common Stock
2026-02-18 Grant 125,000 $0.00
Vanda Pharmaceuticals Inc VNDA
Common Stock
2026-02-18 Grant 125,000 $0.00
Vanda Pharmaceuticals Inc VNDA
Common Stock
2026-02-18 Grant 125,000 $0.00
Vanda Pharmaceuticals Inc VNDA
Common Stock
2025-08-07 Buy 10,000 $4.15 41,500
Vanda Pharmaceuticals Inc VNDA
Common Stock
2025-06-13 Sell 7,000 $4.59 32,130
Vanda Pharmaceuticals Inc VNDA
Common Stock
2025-06-05 Grant 59,225 $0.00
Vanda Pharmaceuticals Inc VNDA
Common Stock
2025-06-05 Grant 59,225 $0.00
Vanda Pharmaceuticals Inc VNDA
Common Stock
2025-06-05 Grant 59,225 $0.00
Vanda Pharmaceuticals Inc VNDA
Common Stock
2025-06-05 Grant 59,225 $0.00
Vanda Pharmaceuticals Inc VNDA
Common Stock
2025-06-05 Grant 59,225 $0.00
Vanda Pharmaceuticals Inc VNDA
Common Stock
2025-05-21 Buy 481 $4.39 2,112
Vanda Pharmaceuticals Inc VNDA
Common Stock
2025-05-21 Buy 9,519 $4.40 41,884
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com